Thomas J. Herzfeld Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$45,000
-16.7%
5,0000.0%0.02%
-19.0%
Q2 2019$54,000
+12.5%
5,0000.0%0.02%
+16.7%
Q1 2019$48,000
-15.8%
5,0000.0%0.02%
-21.7%
Q4 2018$57,000
-32.9%
5,0000.0%0.02%
-23.3%
Q3 2018$85,0005,0000.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders